Assignee
IDENIX PHARMACEUTICALS LLC
US·14 granted patents·12 pending applications·45 citations·filing 2012–2020
Top patents by PatentIndex Score
26 records- 0196US9192621B2Esters and malonates of SATE prodrugsIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Nov 24, 2015·32 cites·22 claims
- 0283US10815264B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Oct 27, 2020·2 cites·10 claims
- 0380US10202411B23′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Feb 12, 2019·3 cites·29 claims
- 0479US10030044B2Nucleotides for the treatment of liver cancerIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jul 24, 2018·4 cites·46 claims
- 0576US2021024565A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 0673US10758557B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS LLC·Filed 2019·Granted Sep 1, 2020·0 cites·19 claims
- 0773US10683321B24′-or nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jun 16, 2020·2 cites·17 claims
- 0873US10363265B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS LLC·Filed 2012·Granted Jul 30, 2019·1 cites·33 claims
- 0973US2018237467A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 1071US10766917B2Nucleotides for the treatment of cancerIDENIX PHARMACEUTICALS LLC·Filed 2016·Granted Sep 8, 2020·1 cites·7 claims
- 1169US10717758B2D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2018·Granted Jul 21, 2020·0 cites·24 claims
- 1268US2017088577A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
- 1365US2018235993A1Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 1456US10513534B22′-chloro nucleoside analogs for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Dec 24, 2019·0 cites·60 claims
- 1556US10238680B2D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Mar 26, 2019·0 cites·21 claims
- 1656US2016280729A1Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcvIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1755US2017198005A12'-dichloro and 2'-fluoro-2'-chloro nucleoside analogues for hcv infectionIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1854US10525072B22′-branched nucleosides and flaviviridae mutationIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Jan 7, 2020·0 cites·12 claims
- 1952US2019365788A1Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesIDENIX PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 2047US2016002281A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2146US10723754B22′,4′-bridged nucleosides for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Jul 28, 2020·0 cites·16 claims
- 2246US2016271162A1D-alanine phosphoramide pronucleotides of 2'-methyl 2'-fluro guanosine nucleoside compounds for the treatment of hcvIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2345US10005779B21′,4′-thio nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jun 26, 2018·0 cites·24 claims
- 2441US2017135990A1Pharmaceutical compositions comprising a 5,5-fused heteroarylene flaviviridae inhibitor and their use for treating or preventing flaviviridae infectionIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2534US2017066779A1Solid forms of a flaviviridae virus inhibitor compound and salts thereofIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2630US2017066795A1Solid prodrug forms of 2'-chloro-2'-methyl uridine for hcvIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →